Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) FCF Margin (2024)

Zentalis Pharmaceuticals has reported FCF Margin over the past 1 years, most recently at 147.78% for Q4 2024.

  • Quarterly results put FCF Margin at 147.78% for Q4 2024, changed N/A from a year ago — trailing twelve months through Sep 2025 was 498.82% (down 7439.0% YoY), and the annual figure for FY2024 was 253.74%, changed.
  • FCF Margin for Q4 2024 was 147.78% at Zentalis Pharmaceuticals, down from 128.24% in the prior quarter.
  • Over the last five years, FCF Margin for ZNTL hit a ceiling of 128.24% in Q1 2024 and a floor of 147.78% in Q4 2024.